7RBQ
Co-crystal structure of human PRMT9 in complex with MT556 inhibitor
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | ALS BEAMLINE 5.0.1 |
| Synchrotron site | ALS |
| Beamline | 5.0.1 |
| Temperature [K] | 100 |
| Detector technology | PIXEL |
| Collection date | 2019-06-12 |
| Detector | DECTRIS PILATUS3 6M |
| Wavelength(s) | 0.97741 |
| Spacegroup name | P 1 21 1 |
| Unit cell lengths | 64.044, 82.061, 65.767 |
| Unit cell angles | 90.00, 97.71, 90.00 |
Refinement procedure
| Resolution | 48.910 - 2.200 |
| R-factor | 0.2154 |
| Rwork | 0.212 |
| R-free | 0.27060 |
| Structure solution method | FOURIER SYNTHESIS |
| RMSD bond length | 0.007 |
| RMSD bond angle | 1.124 |
| Data scaling software | SCALEPACK |
| Phasing software | PHASER |
| Refinement software | REFMAC (5.8.0258) |
Data quality characteristics
| Overall | Inner shell | Outer shell | |
| Low resolution limit [Å] | 50.000 | 50.000 | 2.240 |
| High resolution limit [Å] | 2.200 | 5.970 | 2.200 |
| Rmerge | 0.077 | 0.044 | 0.742 |
| Rmeas | 0.090 | 0.052 | 0.914 |
| Rpim | 0.046 | 0.026 | 0.523 |
| Total number of observations | 116990 | ||
| Number of reflections | 33259 | 1776 | 1375 |
| <I/σ(I)> | 6.1 | ||
| Completeness [%] | 97.1 | 100 | 81.4 |
| Redundancy | 3.5 | 3.7 | 2.5 |
| CC(1/2) | 0.997 | 0.618 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, SITTING DROP | 5.5 | 291 | 25%(w/v)PEG3350, 0.1M Ammonium Sulphate, 0.1M Bis-Tris pH7.4 |






